![]() MBL International MBL International is a life science company providing solutions for researchers in the life sciences, drug discovery and development, and clinical diagnostics fields. | ![]() Eurobio Scientific Eurobio Scientific is a company that develops, produces, and markets reagents for research and biomedical diagnosis. | ![]() Viracta Therapeutics Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients with viral-associated cancers and other serious diseases. | ![]() MedChemExpress MedChemExpress (MCE) is a company offering biochemical and life science research tools. | ||
Founding Date | Founding Date 1993 | Founding Date 1997 | Founding Date 2004 | Founding Date 2016 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Woburn, US HQ | Locations Les Ulis, FR HQ Rockville, US | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations Encinitas, US HQ | Locations South Brunswick Township, US HQ |
Employees | Employees 753% decrease | Employees 1154% increase | Employees 194362% increase | Employees 323% increase | Employees 1012% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 279.9 m | Valuation ($) 515.9 m | Valuation ($) 8.7 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €154.2m (FY, 2024) | Revenue (est.) $109.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €77.2m (FY, 2024) | Cost of goods $12.4m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €77.8m (FY, 2024) | Gross profit $97.3m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income €4m (FY, 2024) | Net income ($153.5m) (FY, 2025) | Net income ($51.1m) (FY, 2023) | Net income N/A |

Eurobio Scientific is a company that develops, produces, and markets reagents for research and biomedical diagnosis.
View company
UroGen Pharma is a clinical-stage biopharmaceutical company.
View company
Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients with viral-associated cancers and other serious diseases.
View company
MedChemExpress (MCE) is a company offering biochemical and life science research tools.
View company